TUBA1B and cancer: The complex interplay between the tumor microenvironment and TUBA1B could potentially modulate the efficacy of therapeutic agents, highlighting the need for a more comprehensive approach that integrates both genomic and microenvironmental factors to overcome drug resistance and optimize treatment strategies, thus offering promising improvements in personalized cancer care and outcomes.